Northern Exposure PR

We are the leading public relations company serving the life science, pharmaceutical and technology industries.

Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.

Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management

Northern Exposure Public Relations  is uniquely skilled in assisting clients in all public relations requirements

Meet Our Team


Richard Kerns

Richard Kerns

Managing Director

Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.

Edward Dutton

Edward Dutton

Vice President

Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.

Sarah Houlton

Sarah Houlton

Technical Consultant in Residence

Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.

Our Services

NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:

Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more. 

Contact us today to find out how we can assist you

Our Clients

Client News

16/01/2018 Cambrex and AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility

30/01/2018 Cambrex Expands Process Research and Development Capabilities Across North America

28/02/2018 Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

12/04/2018 Catalent Completes $5.5 Million Expansion of Clinical Storage at Philadelphia Facility

17/04/2018 SGS Strengthens Belgian Clinical Pharmacology Unit with Appointment of New Medical Director

17/04/2018 Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility

21/04/2018 Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility

24/04/2018 Catalent To Invest $5 million at Somerset Site to Create New Drug Development and Modified Release Center of Excellence

24/04/2018 SGS H3N2 Challenge Virus Wins the Medicine Maker 2017 Innovation Awards

14/05/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars

15/05/2018 Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility

17/05/2018 Catalent Completes $5.5 Million Phased Clinical Storage Expansion at Kansas City Campus

31/05/2018 Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility

31/05/2018 Catalent Biologics Supports InterveXion on New Treatment for Methamphetamine Users

05/06/2018 SGS Quality, Expertise & Reliability Recognized at 2018 CRO Leadership Awards

12/06/2018 Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

13/06/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services

26/06/2018 Catalent Biologics Announces Appointment of Dr. Graham Brearley as General Manager of its Madison, Wisconsin Facility

03/07/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

10/07/2018 Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform to Accelerate Cell Line Development

12/07/2018 Catalent Appoints Marlene Leuenberger as General Manager of New Drug Development Center of Excellence

23/07/2018 Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

14/08/2018 Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

28/08/2018 SGS to Open New Biopharmaceutical Testing Laboratory in Geneva

04/09/2018 SGS Successfully Implements PBMC Analysis for Early Phase Clinical Trials at its Clinical Pharmacology Unit in Antwerp, Belgium

04/09/2018 Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form

10/09/2018 IDEXX Pseudalert Test Accepted as Global ISO Standard

11/09/2018 New SGS Biopharmaceutical Testing Capabilities in Illinois

12/09/2018 Cambrex Completes Acquisition of Halo Pharma

25/09/2018 Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply

26/09/2018 Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies

04/10/2018 Catalent Invests $7.3 Million at its Aprilia, Italy Facility

08/10/2018 Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site

16/10/2018 Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA™ (duvelisib) Capsules

23/10/2018 SGS Introduces New In vitro Toxicology Testing at its Mississauga, Canada, Laboratory

13/11/2018 Catalent to Open Second Clinical Supply Facility in China

13/11/2018 SGS Expands Elemental Impurity Testing Services at its Laboratory in Chennai, India

20/11/2018 Cambrex to Acquire Avista Pharma Solutions

27/11/2018 Catalent Expands Clinical Packaging Capabilities in Shanghai, China

03/12/2018 Catalent Invests $14 Million to Expand Biologics Packaging Capabilities Following Twentieth Commercial Drug Approval at Bloomington, Indiana Site

06/12/2018 Catalent Celebrates 20 Years at Philadelphia Facility

10/12/2018 SGS to expand bioanalytical testing capabilities in France at its Poitiers Laboratory

Upcoming Events

NEPR will be attending the following events:

IDEXX Water UK are braving the heat this weekend to cycle the 60 miles from London to Cambridge for @AmnestyUK Good…
about 6 months ago | @NrthnExposurePR